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ABSTRACT 32 
This research evaluated a method involving provision of a concoction of Boesenbergia 33 
pandurata, Solanum ferox dan Zingimber zerumbet extracts for pathogen prevention in tilapia. The 34 
concentration of each extract was 600 ppm of Boesenbergia pandurata/BP, 900 ppm of Solanum 35 
ferox/SF and 200 ppm of Zingimber zerumbet/ZZ. The examination was performed by issuing two 36 
combinations of extracts (SF:BP, SF:ZZ) against Aeromonas hydrophila and Pseudomonas 37 
fluorescens (105 CFUmL-1). Preventive trials were carried out by providing a concoction of extracts 38 
through intraperitoneal injection (0.1 mL/fish) in tilapia (15±2 g) and the immersion method was 39 
performed by bathing the fish in the extracts for 20 minutes, with pathogen challenging during the 40 
following 24 h being carried out. The composition of the used extract was by SF60:ZZ40; 41 
SF50:ZZ50; BP90:SF10; BP50:SF50; and fish without being given the extract. Haematology and 42 
immunology parameters were observed at the 4th week after challanges with pathogenic bacteria. The 43 
number of white blood cells (WBCs) increased significantly (P <0.05) compared to controls without 44 
extract, with a similar increase observed for red blood cell (RBCs), but heamatocrit (Ht) and 45 
hemoglobin (Hb) values did not significantly increase compared to control. Phagocytic index, 46 
respiratory burst and lysozyme activities also experienced a significant increase in fish fed with 47 
combined extracts compared to controls. The numbers of pathogenic bacteria in the body of the fish 48 
given extract were also lower than the control and significantly different at the 4th week. The results 49 
of this study showed that the administration of a combined extract of SF50: ZZ50 and BP90: SF10 50 
provided the best protection as indicated by relative survival percent (RPS) of 100% after being tested 51 
challenged with A. hydrophila and P. fluorescent by. This study indicates that providing combined 52 
extracts by injection and immersion in the ratio of SF50:ZZ50 has a positive effect in increasing the 53 
non-specific immune system of tilapia and increasing protection against bacterial infections. 54 
 55 
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 57 
INTRODUCTION  58 
The increase of global fish farming has been occurring rapidly, with increased biomass 59 
production, species diversification, geographical expansion and enlarging methods to fulfill the 60 
protein needs of fish. The increase has continually faced challenges due to associated diseases and 61 
health problems of aquacultural animals. Another triggering factor is climate change and the 62 
development of affecting aquaculture technologies in the balance or imbalance of interactions 63 
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between pathogens, hosts and the environment. Almost every year, new aquacultural pathogens are 64 
being isolated and novel diseases continue to be identified in various areas of cultivation and many 65 
species in these areas (Rodger 2018). 66 
Aeromonas hydrophila and Pseudommonas fluorescens are two pathogenic bacteria occurring 67 
throughout the year, with a mortality rate of 60–80% (Hardi et al. 2012, 2016, 2017). Aeromonas 68 
causes loss and destruction of the aquaculture industry around the world (Monette et al. 2006). Fish 69 
infected with these bacteria include (Janda & Abbott 2010) tilapia Oreochromis niloticus (Hardi et 70 
al. 2012), Cyprinus carpio (Sioutas et al. 1991; Monette et al. 2006), Clarias gariepinus (Chowdhury 71 
1998) and indian major carps (Karunasagar et al. 1991). Combined bacterial infections are typically 72 
found in nature with heavier symptoms than in single bacterial infections. Combined infection of A. 73 
hydrophila and P. fluorescens leads to stressed fish, exoptalmia, ulcers and watery organs in the bile 74 
gland rupture. Likewise, combined infections of Streptococcus agalactiae and A. hydrophila cause 75 
tilapia and goldfish to die more rapidly than single bacterial infections (Sugiani et al. 2012; Sumiati 76 
et al. 2015). 77 
Many of the fish diseases or pathogens do not yet have suitable preventative or treatmnent 78 
options. For example, the use of vaccines, imonostimulants, antibacterials, and environmental 79 
management to minimize epidemics. The fish vaccines are particularly varied for freshwater fish 80 
because many strains infect these bacteria. The availability of commercial immunostimulants 81 
deriving from natural ingredients is still limited due to the low level of immunomodulatory 82 
components contained in natural compounds (Pridgeon & Klesius 2012). Some beneficial 83 
immunomodulatory components in plants for fish include levamisole and saponins (Findlay & 84 
Munday 2000) being able to increase the non-specific immune systems activity (phagocytosis 85 
activation of leucocyte and WBC) (Bricknell et al. 2005). The single extract of B. pandurata and Z. 86 
zerumbet plants from East Kalimantan have antibacterial activity in vitro and in vivo against A. 87 
hydrophila bacteria, while a single extract of S. ferox effectively inhibits P. fluorescens infection 88 
(Hardi et al. 2016a, 2016b). That extract can be used for prevention and treatment of infections of 89 
both bacteria in tilapia (Hardi et al. 2017, 2018b). 90 
To increase the immunomodulatory activities from plant extracts, several extracts were 91 
combined in aplication. A concocction of Curcuma longa, Ocimum sanctum and Azadirachta indica 92 
extracts at a ratio of 1:1:1 more effectively inhibits A. hydrophila bacteria in vitro compared to a 93 
single extract of each plant (Harikrishnan & Balasundaram 2008); the combined treatment of three 94 
extracts can increase the survival rate and inhibitory process due to infection by A. hydrophila bacteria 95 
in goldfish (Carassius auratus) (Harikrishnan et al. 2009). A concocction of Boesenbergia 96 
pandurata, Solanum ferox, and Zingiber zerumbet extract at a ratio 1:1:1 in tilapia has an 97 
immunomodulatory effect in tilapia and could increase protection and diseases recovery from A. 98 
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hydrophila and Pseudomonas fluorescens better than single extract (Hardi et al. 2019a). some 99 
research show that B. pandurata and Z. zerumbet extracts contains alkaloids, flavonoids, 100 
carbohydrates, and steroids (Hardi et al, 2016a). While the ekstract of S. ferox has higher levels of 101 
alkaloids that play an important role as antibacterial properties (Hardi et al, 2016a and Huang et al 102 
2008). 103 
A concoction of three extracts of B. pandurata, Z. zerumbet and S. ferox had in vitro 104 
antibacterial activity against A. hydrophila and P. fluerescens both in single and combined use (Hardi 105 
et al. 2018a; 2018b). This paper will discuss the effectiveness of these three extracts to prevent 106 
infection from A. hydrophila and P. fluerescens bacteria in tilapia using injection and immersion 107 
methods. 108 
 109 
MATERIALS AND METHODS  110 
Fish and Bacteria  111 
Tilapia used in this research were of size 15±2 g, taken from the village of Teluk Dalam, 112 
Tenggarong Seberang Kutai Kartanegara. The tilapia fish had been kept at the laboratory for two 113 
weeks prior to use. The aquarium used for treatment was 60 x 40 x 30 cm, containing 60 L of water, 114 
50% of which was changed every two days to remove remaining fish fesses and feed. 115 
The bacteria used for the challenge trial were combination of A. hydrophila (EA-01) and P. 116 
fluerescens (EP-01) with ratio 1:1, derived from the Aquatic Microbiology laboratory, Faculty of 117 
Fisheries and Marine Sciences, Mulawarman University, Indonesia. Bacterial density was 105 118 
CFUmL-1 each bacteria, with 1 mL/fish being injected intramuscularly.  119 
 120 
Extract Preparation for B. pandurata, Z. zerumbet and S. ferox 121 
The rhizomes of plants used in the study were B. pandurata and Z. zerumbet, and fruit of S. 122 
ferox. All of them were collected from traditional markets in Samarinda City, East Kalimantan. Plants 123 
were cleaned of dirt, cut into slices, dried in an oven at 40 oC for 48 hours, blended in powder form 124 
and refrigrated at -4 °C until the extraction stage continued. The method for extraction uses ethanol 125 
solution and follows Limsuwan & Voravuthikunchai (2008). The concentrations of each extract were 126 
B. pandurata and Z. zerumbet, and S. ferox respectively 600, 200 and 900 mgL-1. Comparison of 127 
combination of Z. zerumbet and S. ferox extracts with rasio 40:60 and 50:50 mL. Comparison of B. 128 
pandurata and S. ferox 90:10 mL and 50:50 mL.  129 
 130 
Experiment 131 
Extract was given to tilapia via use of injection and immersion methods to avoid bacterial 132 
infection of A. hydrophila and P. fluerescens. A preventive experiment was performed by issuing 133 
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combined extracts through intraperitional injection (IP) at a rate of 0.1 mL/fish and waiting for seven 134 
days; on the 8th day, fish were challenged with pathogenic bacteria. Regarding the immersion method 135 
for preventing pathogenic bacteria, fish were immersed for 20 minutes with a combination of extracts, 136 
and challenged with the combined bacteria through intramuscular injection (IM) on the 8th day. The 137 
experiment was carried out every week after injecting with bacteria until the 4th week. In addition, 138 
the applied research treatment comprised nine groups: 139 
Group 1  =  IP injected fish with combination of 60 ml of S. ferox extract, 40 ml of Z. zerumbet 140 
extract (SF 60:ZZ 40) and challenge through IM injection with combination of pathogen 141 
bacteria. 142 
Group 2  =  IP injected fish with combination of 50 ml of S. ferox extract and 50 ml of Z. zerumbet 143 
extract (SF 50:ZZ 50) and challenged through IM injection with combination of 144 
pathogenic bacteria. 145 
Group 3 =  IP injected fish with combination of 90 ml of B. pandurata extract and 10 ml of S. ferox 146 
(BP 90:SF 10) and challenged through IM injection with combination of pathogenic 147 
bacteria. 148 
Group 4 =  IP injected fish with combination of 50 ml of B. pandurata extract and 50 ml of S. ferox 149 
extract (BP 50:SF 50) challenged through IM injection with combination of pathogenic 150 
bacteria. 151 
Group 5  =  Immersion fish with combination of 60 ml of S. ferox extract and 40 ml of Z. zerumbet 152 
extract (SF 60:ZZ 40) challenged through IM injection with combination of pathogenic 153 
bacteria. 154 
Group 6  =  Immersion fish with combination of 50 ml of S. ferox extract and 50 ml of Z. zerumbet 155 
extract (SF 50:ZZ 50) challenged through IM injection with combination of pathogenic 156 
bacteria. 157 
Group 7 =  Immersion fish with combination of 90 ml of B. pandurata extract and 10 ml of S. ferox 158 
extract (BP 90:SF 10) challenged through IM injection with combination of pathogenic 159 
bacteria. 160 
Group 8 =  Immersion fish with combination of 50 mL of B. pandurata extract and 50 ml of S. ferox 161 
extract (BP 50:SF 50) challenge via IM injection with combination of pathogenic 162 
bacteria. 163 
Group 9 =  IP injected fish with PBS (phosphat buffer saline) sterile and challenge through IM 164 
injection with combination of pathogen bacteria.  165 
Group 10 =  Immersion fish with PBS sterile and challenge via IM injection with combination of 166 
pathogenic bacteria. 167 
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In this research, every group using 10 fish every aquarium and three replication, so 30 fish 168 
using every groups, to evaluate the effective method.  Total tilapia were used in this research to 169 
evaluate the extract administration with the different method (IP and immersion) in non-specific 170 
immunity, susrvival rate (SR), and Relative Percent Survival (RPS) were 300 Oreochromis niloticus. 171 
 172 
Hematological Examination  173 
Every week (first, second, third and fourth) during one month after challenging with 174 
pathogenic bacteria, hematological observations were obtained. Before blood was taken, the fish were 175 
anesthetized using 50 mg MS-222 dm-3, and blood was obtained through the base of the fish, with 1 176 
ml of injection syringe being washed with anticoagulants (10% tri sodium citrate). Red Blood Cells 177 
(RBC)  and White Blood Cells (WBC)  parameters were observed using a Neubauer haemocytometer. 178 
Observation of RBC begins by adding blood samples with Hayem's solvent and adding Turk's solvent 179 
for the observation of WBC. Hemoglobin examination involved use of a sahli tube. Hematocrit (Ht 180 
%) was measured using the microcentrifuge method, and the standard solvent employed was tri 181 
sodium citrate. The inserted blood into the micro hematocrit tube was centrifuged at 7,000 g for 10 182 
min. Hematocrit is estimated by calculating the ratio of the column of packed erythrocytes to the total 183 
length of the sample in the capillary tube, measured with a graphic reading device (Blaxhall and 184 
Daisley Methods, 1973). 185 
 186 
Index Phagocytic 187 
Fifty μL of blood was transferred into an eppendorf tube containing 50 μL, mixed of  A. 188 
hydrophila and P. fluorescens suspension (the density of each bacteria were 105 CFUmL-1), and left 189 
for 20 minutes. The preparation of the screw was made on a glass object and dried, fixed with alcohol 190 
(95%) for five minutes, then dried again. The preparation was then coloured by soaking it in Giemsa 191 
dye (10%) for 15 minutes, washed with flowing water and dried. The preparations were then observed 192 
and the number of cells demonstrating phagocytic processes were counted (100 phagocytic cells were 193 
observed), the method according to Anderson and Siwicki (1995). This parameter was observed in 194 
week 4th after chalanges (IM) with A. hydrophila and P. flourescens. 195 
 196 
Respiratory Burst  197 
The test of respiratory burst activity involved use of nitro blue tetrazolium (NBT) reagent. 198 
Blood derived from fish (50 μL) was transferred to a microplate, incubated for one hour at 37 ° C, 199 
the supernatant removed; cells were washed with 50 μL of PBS three times, 50 μL of 0.2% NBT was 200 
added and incubated for one hour at 37 ° C. Plates were fixed with 100% methanol (50 μL) for 2–3 201 
minutes, then rinsed with 30% methanol (50 μL) three times and air-dried. Then, 60 μL of KOH and 202 
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70 μL of DMSO were added, with the optical density then checked using an ELISA Reader at a 203 
wavelength of 540 nm the paramether analized by Secombes and Fletcher (1992) method. Likes a 204 
index phagocity, this parameter was observed in week 4th after chalanges (IM) with A. hydrophila 205 
and P. flourescens. 206 
 207 
Lysozyme Activity  208 
Moistened injection syringes with anticoagulants were prepared, with the blood of the fish 209 
from the caudal vein  taken. Blood was stored at room temperatue for two hours and then maintained 210 
at 4 °C for 24 hours. Blood was centrifuged at 5,000 rpm for three minutes, with the separated clear 211 
liquid (serum) then being removed. The test for lysozyme activity was performed according to the 212 
method of Lygren et al. (1999) — 10 µl of serum sample was placed into a micro titer plate and then 213 
190 μl of lysodeikticus Micrococcus suspension added (Sigma Aldrich Chemical) (0.2 mg of 214 
lysodeikticus Micrococcus / mL PBS (pH 7.4)) shaking slowly at constant room temperature. After 215 
90 minutes of incubation, a micro titer ELISA plate reader at a wavelength of 520 nm (Lie et al. 1989) 216 
was used to take readings.  217 
Relative lysozyme activities (units) were calculated as follows: 1 Unit = 0.001 decrease in 218 
absorbance/minute. If the calculation of lysozyme activity is absolutely necessary, it can use a 219 
standard solution of chicken egg white with several concentrations in order to ensure that the standard 220 
measurement procedure curve is the same. The paramether analized according to Lygren et al. (1999) 221 
and observed in week 4th after chalanges (IM) with A. hydrophila and P. flourescens. 222 
 223 
Total Bacteria in Fish Bodies using TPC  224 
Calculation of total bacteria in the fish body was carried out to determine the antibacterial 225 
activity due to injection with combined extracts of A. hydrophila and P. fluorescens. The 226 
measurement of total bacteria using the TPC method was performed by counting the number of 227 
bacterial colonies in the fish's organs using 10-2 to 10-6 dilutions. The initial bacterial concentration 228 
was calculated using plates containing 30–300 colonies.  229 
As a first step, petri cups, test tubes and pipettes were sterilized using dried sterilization (180 230 
oC for two hours) prior to use. PCA solid media were used as a growth substrate, wet-sterilized in an 231 
autoclave (121 oC for 15 minutes, 1 atm). Samples of ten grams of fish (thymus, kidney, spleen, and 232 
liver), were mashed first, then dissolved in 100 ml of sterile diluent solvent to obtain a 10-1 dilution. 233 
One ml was then taken, and put in sample tubes containing 9 ml of sterile distilled water (10-2) until 234 
a dilution of 10-6 was achieved. A total of 1 ml of each tube was transferred into a sterile petri cup 235 
and approximately 15 mL of PCA media was poured evenly; the petri dish was incubated for 48 hours 236 
at 30 °C (the petri dish was placed upside down in the incubator) and growing colonies then counted, 237 
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based of Mailoa et al. (2017) method. At the end of the incubation period, select all of the petri plates 238 
containing between 30 and 300 colonies. Plates with more than 300 colonies cannot be counted and 239 
are designated too many to count (TMTC). Plates with fewer than 30 colonies are designated too few 240 
to count (TFTC). Count the colonies on each plate and a quebec colony counter should be used. This 241 
parameter was observed in week 4th after chalanges (IM) with A. hydrophila and P. flourescens. 242 
 243 
number of colonies (CFU)/mL =
Colony of bacteria
𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑋 𝑎𝑚𝑜𝑢𝑛𝑡 𝑝𝑙𝑎𝑡𝑒𝑑 
 244 
 245 
Protection Level for Pathogens 246 
To determine the effectiveness of combined extracts to prevent A. hydrophila and P. 247 
flurescens infection, the challenge-tested fish were counted with respect to number survival rate (SR) 248 
and the protection level (RPS) was calculated on week 4th after IM infectio, and observations using 249 
the Amend (1981) and Ellis formula (1988). 250 
SR =
(𝑎𝑙𝑖𝑣𝑒 𝑓𝑖𝑠ℎ 𝑎𝑡 𝑡ℎ𝑒 𝑒𝑛𝑑 𝑜𝑓 𝑡ℎ𝑒 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡)
(𝑎𝑙𝑖𝑣𝑒 𝑓𝑖𝑠ℎ 𝑎𝑡 𝑡ℎ𝑒 𝑏𝑒𝑔𝑖𝑛𝑛𝑖𝑛𝑔 𝑜𝑓 𝑡ℎ𝑒 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡)
𝑋 100 251 
 252 
RPS = 1 −
(𝑝𝑒𝑟𝑐𝑒𝑛𝑡 𝑚𝑜𝑟𝑡𝑎𝑙𝑖𝑡𝑦 𝑖𝑛 𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑔𝑟𝑜𝑢𝑝)
𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝑚𝑜𝑟𝑡𝑎𝑙𝑖𝑡𝑦 𝑖𝑛 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑔𝑟𝑜𝑢𝑝
𝑋 100 253 
Statistics Data analysis 254 
The data obtained were analyzed statistically using SPPS 16.0 to determine the effect of extract 255 
treatment on observation parameters. 256 
 257 
RESULTS AND DISCUSSION 258 
Hematology 259 
The total tilapia WBCs to prevent bacterial infection of A. hydrophila and P. fluorosence 260 
using the immersion method (Table 1) significantly increased (P <0.05) starting from the 2nd week to 261 
the 4th week after being given the combined extract (Group 5-Group 8) compared with controls 262 
(Group 10) without extract. The highest increase was experienced by tilapia given the combined 263 
extract of B. pandurata and S. ferox at a 50:50 of ratio (Group 6) from the 2nd  week to the 4th week 264 
after bacterial infection by IM. Likewise, total RBC counts (Group 5-Group 8) significantly increased 265 
with control fish (P <0.05) since the second week of treatment, while hematocrit levels (Group 5-266 
Group 8) significantly increased (P <0.05) in weeks 3 and 4. Post-treatment tilapia hemoglobin levels 267 
in Group 5-Group 8 were increased but not significantly different to control/Group 10 (P <0.05). 268 
 269 
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Table 1. Haematology of tilapia in preventive method using a combination of extracts to bacterial 270 
infection of A. hydrophila and P. fluorosence through immersion methods  271 
Variable Groups Extracts 
Weeks 
1 2 3 4 
WBC (104 
cell/mm3) 
5 SF 60 : ZZ 40 1.50.1a 1.40.1a 1.60.1a 2.00.2b 
6 SF 50 : ZZ 50 2.00.2b 3.20.1b 3.80.2c 7.60.2d 
7 BP 90 : SF 10 1.70.2b 1.70.5b 2.00.1b 2.00.1b 
8 BP 50 : SF 50 1.90.5b 1.70.5b 1.80.2b 2.00.1b 
10 No extract 1.30.3a 1.30.2a 1.30.2a 1.30.1a 
RBC (106 
cell/mm3) 
5 SF 60 : ZZ 40 5.90.1b 5.00.b 4.00.2 5.30.1 
6 SF 50 : ZZ 50 5.90.1b 7.00.2c 7.80.1c 6.90.2c 
7 BP 90 : SF 10 5.10.2b 6.00.1c 6.20.1c 4.40.2b 
8 BP 50 : SF 50 5.20.1b 6.00.2c 6.00.1c 6.70.1c 
10 No extract 2.00.3a 2.00.1a 2.70.2a 2.40.1a 
Hematokrit 
(%) 
5 SF 60 : ZZ 40 200.1a 230.1a 270.1b 300.1b 
6 SF 50 : ZZ 50 20.50.5a 230.2a 280.1b 300.2b 
7 BP 90 : SF 10 22.50.5a 230.2a 300.1b 310.2b 
8 BP 50 : SF 50 250.2a 230.2a 270.2b 300.2b 
10 No extract 200.2a 150.3a 180.1a 150.2a 
Hemoglobin 
(g%) 
5 SF 60 : ZZ 40 80.1a 80.3a 80.1a 80.1a 
6 SF 50 : ZZ 50 100.2a 80.3a 100.2a 80.1a 
7 BP 90 : SF 10 80.11a 80.2a 100.2a 100.1a 
8 BP 50 : SF 50 80.1a 80.2a 80.2a 100.1a 
10 No extract 6.30.5a 80.1a 60.2a 60.2a 
Notes: Values (means  SD) with different superscript in a row show significant differences (P < 272 
0.05). 273 
 274 
Preventive test throug the injection (IP) method (Table 2) showed that WBC had the highest 275 
increase in tilapia using the treatment ratio of SF 50: ZZ 50 (Group 2). The increase was significantly 276 
different with the control/Group 9 (P <0.05) in Group 1-Group 4 treatment by IP from 1st to 4th week 277 
of observations. A similar result was showed RBC and hematocrit, with results for fish given extracts 278 
being significantly different (P <0.05) to control. Only fish heamoglobin (Group 1-Group 4) was not 279 
significantly different with the fish control in terms of prevention of bacterial infections via the IP 280 
method. 281 
 282 
Table 2. Haematology of tilapia in preventive testing using a combined extract against bacterial 283 
infection of A. hydrophila and P. fluorosence through IP method 284 
Variable Groups Extracts 
Weeks 
1 2 3 4 
WBC (104 
cell/mm3) 
1 SF 60 : ZZ 40 1.70.5a 2.20.15a 1.80.2a 1.80.5a 
2 SF 50 : ZZ 50 3.40.3b 4.30.2b 4.00.1b 4.90.2c 
3 BP 90 : SF 10 2.00.15a 2.70.2a 2.40.1a 2.40.3a 
4 BP 50 : SF 50 2.40.25a 2.80.3a 2.00.2a 2.50.1a 
9 No extract 1.50.1a 1.30.5a 1.30.3a 1.30.1a 
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RBC (106 
cell/mm3) 
1 SF 60 : ZZ 40 7.40.15d 6.80.25c 5.90.2c 6.00.5c 
2 SF 50 : ZZ 50 7.90.2d 7.70.3d 6.00.1c 6.00.2c 
3 BP 90 : SF 10 5.50.1b 6.60.1c 5.00.1b 5.40.2b 
4 BP 50 : SF 50 5.80.1b 5.80.1b 7.70.1c 7.00.1c 
9 No extract 2.40.2a 2.60.2a 2.70.2a 2.40.1a 
Hematokrit (%) 
1 SF 60 : ZZ 40 310.5b 250.1a 220.1a 220.1a 
2 SF 50 : ZZ 50 22.20.15a 250.2a 200.2a 220.1a 
3 BP 90 : SF 10 250.1a 250.1a 300.2a 21,50.1a 
4 BP 50 : SF 50 250.2a 250.1a 250.1a 210.2a 
9 No extract 200.1a 150.2a 140.1a 150.1a 
Hemaglobin 
(g%) 
1 SF 60 : ZZ 40 100.2a 100.1a 80.2a 90.2a 
2 SF 50 : ZZ 50 100.2a 100.1a 80.2a 90.1a 
3 BP 90 : SF 10 100.2a 100.1a 80.1a 80.1a 
4 BP 50 : SF 50 100.2a 100.1a 80.1a 80.2a 
9 No extract 6.30.2a 70.1a 50.1a 40.1a 
Notes: Values (means SD) with different superscript in a row show significant differences (P < 285 
0.05). 286 
 287 
Index Phagocytic 288 
The fish given the combined extract of SF 50: ZZ 50 (Group 2) through the injection method 289 
(IP) showed the highest index phagocytic improvement compared to the other treatments (Group 1, 290 
3,4,5,6,7,8) at the 4th week after the challenge test and were significantly different to the 291 
controls/Group 9 (P <0.05). Likewise, with the immersion method, prevention from bacterial 292 
infections of A. hydrophila and P. fluorescens with a combined extract of SF 50: ZZ 50 (Group 6) 293 
showed the highest increase of index phagocytic in the 4th week after the challenge (IM) test. The 294 
entire treatment of the extract combination was increased and significantly different from the control 295 
(P <0.05).  All combination of extract (Group 1- Group 8) were increased in index phagocytic and 296 
significantly to the controls in the 4th week after the challenge test (Figure 1). 297 
 298 
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Figure 1.  Index phagocityc of tilapia on challenge test using combined extract to bacterial infection 300 
of A. hydrophila and P. fluorosence through injection and immersion methods.  301 
Different superscript in a row show significant differences (P < 0.05). 302 
 303 
Respiratory Burst 304 
Respiratory burst activity of tilapia given a combination of extracts increased during the 4th 305 
week either through injection or immersion methods (Figure 2.). A significant increase compared to 306 
the control group occurred in all given extracts with different combinations. However, only the ratio 307 
of SF 50:ZZ 50 by IP method (Group 2) was significantly different (P<0.05) from the combination 308 
of other extracts and to the controls (Group 9). 309 
 310 
 311 
Figure 2. Respiratory burst activity of tilapia on preventive methods by using a combination of 312 
extracts to bacterial infection of A. hydrophila and P. fluorosence through injection and 313 
immersion method 314 
 315 
Lysozyme Activity 316 
The activity of tilapia lysozyme given all combination of extracts (Group 1-Group 8) with 317 
different comparisons were increased, and significantly different to control without extract (P> 0.05) 318 
in the 4th week after the challenge test. Only Group 2 was significantly different to others concocction 319 
extract (Figure 3). But the all conccoction of extract (Group 1- Group 8) were significantly different 320 
to contol (Group 9 and Group 10) without extract (P > 0.05). 321 
 322 
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 323 
Figure 3.  Lysozyme activity of tilapia in preventive method by using a concocction extract to 324 
bacterial infection of A. hydrophila and P. fluorosence through injection and immersion 325 
methods 326 
 327 
The total bacteria of A. hydrophila and P. fluorescens in the body of tilapia in prevention 328 
through injection (IP) and immersion methods were lower than controls (Group 9 and Group 10) 329 
without extracts at the 4th week after the challenge test (IM) with pathogenic bacteria (Table 3). The 330 
lowest bacterial density in tilapia was found for those fish given a combination extract of SF 50: ZZ 331 
50 (Group 2) and different control with no extract/ Group 9 (P <0.05), as well as for the combined 332 
extract of BP 90: SF 10 (Group 3), in which the total value of bacteria was lower than the control 333 
(Group 9) and was significantly different (P <0.05). All concocction of extract (Group 1-Group 8) 334 
coused total bacteria decreased in tilapia on week 4th after chalanges with A. hydrophila and P. 335 
fluorescent (IM). The decreased of total bacteria was significantly to the control (Group 9 and Group 336 
10) with P <0.05. The concocction SF 50 : ZZ 50 and BP 90 : SF 10 (Group 2 and Group 3) were 337 
injection (IP) administration can supress the bacterial growth in the fish body and significantly to the 338 
others cocccoction. While, only the concocction SF 50 : ZZ 50 (Group 6) by immersion 339 
administration was significantly with the others coccoction and to the control/Group 10 (P <0.05). 340 
 341 
Table 3. TPC of tilapia bacteria in preventive method by using combination of extracts to bacterial 342 
infection of A. hydrophila and P. fluorosence through injection and immersion methods 343 
Groups Extracts Total Bacteria (105 CFUmL-1) 
1 IP SF 60 : ZZ 40 12010c 
2 IP SF 50 : ZZ 50 325b 
3 IP BP 90 : SF 10 557b 
4 IP BP 50 : SF 50 11711c 
5 Immersion SF 60 : ZZ 40 1409c 
6 Immersion SF 50 : ZZ 50 455b 
7 Immersion BP 90 : SF 10 988c 
8 Immersion BP 50 : SF 50 11010c 
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9 IP control 25711a 
10 Immersion control  30011a 
Notes: Values (means SD) with different superscript in a row show significant differences (P < 0.05) 344 
 345 
Prevention against A. hydrophila and P. fluorosence 346 
The highest percentage of  SR and RPS of tilapia in preventive methods against A. hydrophila 347 
and P. fluorosence use were found on tilapia that had been given extracts SF 50:ZZ 50 (Group 2) and 348 
BP 90:SF 10 (Group 3) by injection until week 4. Meanwhile, the average SR of tilapia that were 349 
given a concoction of extract was demonstrated to be higher than controls/ Group 9 and Group 10 350 
(Table 4). The best SR and RPS of tilapia preventive using immersion method had given extracts SF 351 
50:ZZ 50 (Group 6) than others concocction (Groups 5, 7, 8) but, Groups 5, 7, and 8 ware increase 352 
the SR and significantly diferent to the control (Group 10) with P<0.05.   353 
Relative percent survival in all groups that administration with the concocction extracts were 354 
more than 65 %, only on Group 7 (Immersion BP 90 : SF 10) that lowest RPS (58%).  Hardi et al 355 
(2018a), Ellis (1988), Osman et al (2009) says that RPS more than 60% showed the vaccine or 356 
immunostimulant ware effective in protection bacteria infection. 357 
 358 
Table 4. Survival Rate and RPS of tilapia bacteria in preventive method by using combination of 359 
extracts to bacterial infection of A. hydrophila and P. fluorosence through injection and 360 
immersion method 361 
Groups Extracts SR RPS 
1 IP SF 60 : ZZ 40 8810
b 8310b 
2 IP SF 50 : ZZ 50 10010c 10010c 
3 IP BP 90 : SF 10 10010c 10010c 
4 IP BP 50 : SF 50 8510b 7910b 
5 Immersion SF 60 : ZZ 40 7510b 6510b 
6 Immersion SF 50 : ZZ 50 8010b 7210b 
7 Immersion BP 90 : SF 10 7010b 5810b 
8 Immersion BP 50 : SF 50 7510b 6510b 
9 IP Control  2910a  
10 Immersion Control 2910a  
Notes: Values (means SD) with different superscript in a row show significant differences (P < 0.05) 362 
 363 
The use of immunostimulants and antibacterials derived from plant extracts has been 364 
previously carried out for fish and shrimp cultures for Aeromonas salmonicida, A. hydrophila, Vibrio 365 
anguillarum, V. vulnificus, V. salmonicida, Yersinia ruckeri and Streptococcus spp. (Barman et al. 366 
2013). According to Sakai (1999) and Findly & Munday (2002), immunostimulants are additional 367 
ingredients given to organisms and are able to increase the innate (non-specific) immune system to 368 
prevent pathogenic infections. Cells playing important roles in the non-specific immune system are 369 
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WBCs; their activity is influenced by fish, nutrition and the environment (Harrikrishnan et al, 2003; 370 
Mastan, 2015). The increase of WBCs of tilapia given all concoction extract (Group 1-8) was higher 371 
than the control without extract (Group 9 and 10), and the survival rate of tilapia after A. hydrophila 372 
and P. fluorescens infection reached 100% using a combination of SF 50: ZZ 50 and BP 90: SF 10 373 
through injection (Group 2 and Group 3). Immersion administration method, give a infection 374 
protection around 58-72%, and the best protection agains bacteria shown in Group 6 (immersion SF 375 
50: ZZ 50) was 72%.  376 
The difference methods in administration of extracts in fish affects on protection against 377 
bacteria infection. These results demonstrate that giving a combination of extracts can improve the 378 
non-spatial performance of the immune system of fish by producing more WBCs, subsequently 379 
inhibiting bacterial growth in the body (as can be seen in the lowest bacterial TPC data in this 380 
treatment compared to other combined extracts or control), and the different methods (IP and 381 
immersion) of administration show differences in performance of the immune system. Hardi et al 382 
(2019b) explain that the that the addition of combined extract into feed has a positive effect on the 383 
tilapia's immune system and the SF50/ZZ50 combination appears to improve the innate immune 384 
system of tilapia to treat and prevent bacterial infections throug feed. 385 
Based on Yin et al (2006), Jeney and Anderson (1993), and Mulero (1998) researchs, the 386 
administration of extract can be applied via injection, bathing or oral administration, the latter seems 387 
to be the most practicable in fish. Both injection and immersion methods have a different advantages 388 
and disadvantages (Evensen, 2016). Advantages the injection method are most potent, little waste of 389 
immonostimulan, Cost-effective method for high-value species. And the immersion method 390 
advantages are large-scale application possible, moderate stress to the fish, allows mass vaccination 391 
or immunostimulant of immunocompetent fish. Evensen (2016) exlpaint abaout the disadvantages 392 
using immersion method than injection.  Immersion method need a large amount of immonostimulan 393 
is needed, can be cost prohibitive, low to moderate efficacy and inferior to injection delivery in terms 394 
of efficacy Cost prohibitive for large fish.  Based on research shows that the injection method can 395 
increase RPS rather than immersion at the same time. This is due to immonostimulant delivery in the 396 
body of the fish. The injection method, immunostimulant directly into the blood, while the immersion 397 
method, immonostimulan must penetrate the fish skin, so that more time is needed to improve the 398 
immune system, the same statement was explain by Midtlyng (2006). 399 
The efficiency of method in immunotimulant admistration in fish, can shown by RPS. The 400 
vaccine or immonostimulant potency and efficacy testing methods in fish and proposes detailed 401 
recommendation of test setup, challenge conditions and outcome acceptance criteria for controlled 402 
trials: exposure by bath challenge in two concentrations; maximum 10% non-specific mortality and 403 
20% within-group variation after challenge; control mortality ≥60 %, vaccinate mortality ≤24 %; and 404 
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following the Amend (1981) recommendations, the proposed acceptance criteria for potency equate 405 
to a standardised RPS of 60 % or above. 406 
The total value of Tilapia RBCs in the preventive trial was higher than the control without 407 
extract, and significantly different (P <0.05). Both A. hydrophila and P. fluorescens bacteria produce 408 
hemolysin protein which can lyse RBCs, the numbers of which are therefore decreased in infected 409 
fish (Hardi et al. 2013). This decrease has also been noted to occur in tilapia infected with S. 410 
agalactiae (Hardi et al, 2011), S. iniae (Sugiani et al. 2012), A. hydrophila (Dosim et al. 2006) and 411 
Pseudomonas sp. Tilapia being injected with extracellular and intracellular proteins from A. 412 
hydrophila (Hardi et al. 2013) and Pseudomonas sp. has been found to lead to degeneration, necrosa 413 
and bleeding in kidney organs, subsequently affecting fish blood production (Hardi et al. 2014). 414 
However, similar observations were not observed for tilapia given combination of extracts 415 
(both methods administration), with RBC values being noted after infection. Hemoglobin (Hb) and 416 
hematocrit (Ht) values did not change in the first week with all treatments and the immersion or 417 
injection method administration including controls, and decreased values of Ht and Hb occurred in 418 
controls without extracts from 2nd and 4th weeks after injection and immersion application methods, 419 
whereas in the treatment fish given extract, Ht and Hb values were relatively increased but not 420 
significantly different between the difference in extract comparison. 421 
The concentration decrease in RBC, Hb and Ht in tilapia that were not given extracts of B. 422 
pandurata, S. ferox, and Z. zerumbet with different concoctions in this study was due to bacterial 423 
infections of A. hydrophila and P. fluorescens (Hardi et al. 2013). According to Scott and Rogers 424 
(1981), Ht is the proportion of the volume of RBC in the blood. For a further explaination, the content 425 
of Hb in catfish has been found to decrease due to swelling of RBCs and the presence of poor Hb 426 
mobilization of the spleen and kidneys. Scott and Rogers (1981) noted that spleen disorders can cause 427 
an increase of Ht levels due to the introduction of erythrocytes into the circulatory system.  428 
The total bacteria in the fish body were decrease in fish extract groups than control groups. 429 
flavonoids, alkaloid, and steroids are antibacterial substance or metabolic secunder, that have ability 430 
to inhibit the growth of bacteria. Extract of B. pandurata contains alkaloids, flavonoids and 431 
carbohydrates and Z. zerumbet contains alkaloids, flavonoids, steroids and carbohydrates, which are 432 
able to suppress the bacteria growth (Hardi et al, 2016a) and Wink (2010). Ekstract of S. ferox has 433 
higher levels of alkaloids that play an important role as antibacterial properties (Hardi et al, 2016a 434 
and Huang et al 2008). Flavonoids and alkoloids could damage the wall surface of the bacteria that 435 
grow, particularly at low temperatures and fatty acids are believed to damage the structure and 436 
function of the bacterial cell wall and membrane (Hayes & Berkovitz 1979). This reseach showed 437 
that the extract improve the non specific immunity, supress the bacteria growth, and increase the 438 
bacterial infection protection. 439 
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 440 
CONCLUSION 441 
This study demonstrates that a concoction of an extract with a ratio of SF 50: ZZ 50 and BP 442 
10:SF 10 provides the best protection against A. hydrophila and P. fluorescent bacterial infections 443 
through injection and SF 50:ZZ 50 is the best ratio to protect the both bacteria infection in immersion 444 
methods. But, the injection is the better method to increase the innate (non-specific) immune system 445 
and protection againts A. hydrophila and P. fluorescens infection quicly than immersion. However, 446 
the concoction extracts ratio SF 50: ZZ 50 were increase immunity of non-specific tilapia and protect 447 
bacterial infection througt injection or immersion. 448 
 449 
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